Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Hemodial Int. 2012 Mar 13;16(3):377–386. doi: 10.1111/j.1542-4758.2012.00676.x

Table 3.

Kidney Disease-Targeted Scale Scores

Scale CHD-CHD (n=13) CHD-DHD (n=10) TRANSPLANT (n=20) P for change among groups

Symptoms
    Baseline 87.9 (9.1) 80.7 (10.9) 80.8 (11.5)
    6 months 87.5 (7.4) 82.8 (9.3)b 91.8 (8.7)
adjusted mean change* (95% CI) 1.2 (-3.3, 5.9) 0.5 (-4.8, 18.4) 8.8 (5.2, 12.4) 0.01

Effects of Kidney Dz
    Baseline 69.5 (23.3) 64.8 (28.3) 72.4 (19.8)
    6 months 67.7 (18.7)b 78.7 (16.3)bc 95.1 (5.4)
adjusted mean change* (95% CI) -1.9 (-8.1, 4.3) 10.9 (3.5, 18.4) 18.6 (5.2, 12.4) <0.001

Burden of Kidney Dz
    Baseline 64.9 (27.5) 42.3 (29.3)a 46.1 (24.2)a
    6 months 60.5 (28.2)b 49.3 (9.1)bc 76.5 (20.3)
adjusted mean change* (95% CI) 0.9 (-8.8, 4.3) 4.2 (-7.2, 15.5) 24.4 (16.8, 32.1) 0.001

WORK
    Baseline 50.0 (45.6) 50.0 (43.3) 77.5 (37.9)
    6 months 46.1 (47.7)b 45.0 (36.6)b 85.0 (28.5)
adjusted mean change* (95% CI) -8.8 (-24.3,6.7) -1.9 (-20.0, 16.2) 13.9 (1.2, 26.6) 0.07

Cognitive Function
    Baseline 89.7 (13.5) 85.1 (10.9) 79.6 (21.7)
    6 months 85.6 (15.1) 91.3 (7.0) 88.3 (14.9)
adjusted mean change* (95% CI) -1.1 (-8.7, 6.5) 6.2 (-2.6, 15.1) 2.4 (-3.6, 8.5) 0.45

SLEEP
    Baseline 39.8 (13.4) 45.0 (8.6) 41.6 (11.4)
    6 months 42.3 (10.0) 44.0 (15.5) 36.2 (10.8)
adjusted mean change* (95% CI) 2.02 (-2.7,6.8) -2.5 (-8.2, 3.1) -5.3 (-9.0, -1,4) 0.21

Sexual Functioning
    Baseline 85.5 (11.1) 90.3 (17.4) 83.1 (23.0)
    6 months 82.7 (14.1) 87.5 (9.8) 90.0 (21.6)
adjusted mean change* (95% CI) 6.5 (-7.1,20.2) 4.3 (-10.7, 19.4) 5.8 (-4.1, 15.8) 0.97

Unless otherwise indicated, values are given as mean ± standard deviation.

Abbreviations:

CHD-CHD, remaining on conventional hemodialysis therapy; CHD-DHD, conventional hemodialysis to daily hemodialysis therapy; TRANSPLANT, received kidney transplant

*

adjusted mean change for baseline values (95% confidence intervals)

a

p<0.01 compared to CHD at visit 1

b

p<0.01 compared to TRANSPLANT at visit 2

c

p<0.01 compared to CHD at visit 2